The Future of Abbvie Inc: Analyzing ABBV

In terms of market performance, Abbvie Inc had a fairly even. The highest value for the stock in the past year was $182.89 on 03/12/24, and the lowest value was recorded at $130.96 on 06/28/23.

52-week price history of ABBV Stock

Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Abbvie Inc’s current trading price is -3.09% away from its 52-week high, while its distance from the 52-week low is 35.34%. The stock’s price range during the 52-week period has remained between $130.96 and $182.89. In the Healthcare sector, the company’s shares saw a trading volume of around 2.0 million for the day, which was evidently lower than the average daily volume of 5.6 million over the past three months.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Market Capitalization and Financial Performance: An In-Depth Look

Abbvie Inc (ABBV) has experienced a quarterly rise of 10.90% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 313.10B and boasts a workforce of 50000 employees.

Making Sense of Trading Volume and Moving Average Data

Based on Barchart.com data, the company’s moving average over the 100-day period was 163.03, with a change in price of +35.30. Similarly, Abbvie Inc recorded 5,557,373 in trading volume during the last 100 days, posting a change of +24.83%.

Examining ABBV’s Debt-to-Equity Ratio: What You Need to Know

The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ABBV stands at 5.80. Similarly, the long-term debt-to-equity ratio is also 5.11.

ABBV Stock Stochastic Average

Abbvie Inc’s raw stochastic average for the past 50 days is presently 73.15%, as of today. This marks a increase from the raw stochastic average of the last 20 days, which was 24.16%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 54.56% and 71.15%, respectively.

ABBV Stock Price Performance Analysis

The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Until today this year the stock’s price performance recorded an increase of 14.37%. However, over the last six months, the performance has been weaker by 19.56%. The price of ABBV increased 0.11% over the last 30 days. And in the last five days, it has fallen by -1.08%.

On Key

Related Posts